[144] Ares Management Corporation SEC Filing

Rhea-AI Filing Summary

Ares Management Corporation (ARES) Form 144 notice reports a proposed sale of 56,204 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $10,704,051.80 and approximately 215,934,693 shares outstanding. The shares were acquired as founders shares on 05/02/2014 and payment was recorded on that date.

The filing also discloses multiple recent 10b5-1 sales by ATTICUS ENTERPRISES LLC in May 2025: 182,108 shares on 05/16 (gross proceeds $30,970,870.82), 93,184 on 05/19 ($15,735,646.62), 150,000 on 05/20 ($24,955,305.00), and 107,500 on 05/21 ($17,344,361.75). The filer includes the standard representation that no undisclosed material information is known.

Positive

• Sale is routed through a registered broker (Morgan Stanley Smith Barney), indicating orderly execution.
• Transactions include 10b5-1 sales, suggesting trades were executed under preplanned instructions.
• Filer affirms no undisclosed material information, meeting Rule 144 attestation requirements.

Negative

• Significant recent insider-related selling in May 2025 (totaling hundreds of thousands of shares) increases share supply.
• Aggregate proceeds from recent sales are material (multiple transactions exceeding tens of millions of dollars).

Insights

Securities Analyst

TL;DR: Insider-related holdings are being sold under Rule 144 and multiple 10b5-1 transactions occurred recently, indicating planned, structured liquidity.

The filing documents a planned sale of 56,204 founder shares via a broker and confirms those shares were acquired in 2014. The disclosure of several large 10b5-1 sales by ATTICUS ENTERPRISES LLC earlier in May 2025 shows substantial recent liquidity events linked to the same beneficial owner. For investors, the sales are transparent and follow Rule 144/10b5-1 procedures, reducing execution risk but increasing outstanding supply in the market during May–August 2025.

Corporate Governance Expert

TL;DR: The notice is a routine compliance filing; it documents founder-share disposition and appropriate 10b5-1 disclosures.

The submission contains required representations about absence of undisclosed material information and ties the proposed sale to founder shares acquired in 2014. Multiple documented 10b5-1 trades demonstrate an established trading plan or instructions, which supports procedural compliance. There is no disclosure here of any change in management, corporate actions, or new material facts beyond the sales activity.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	56204	10704051.80	215934693	08/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/02/2014	Founders Shares	Issuer			56204	05/02/2014	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ATTICUS ENTERPRISES LLC 1800 Avenue of the Stars, Suite 1400 Los Angeles CA 90067	Common	05/21/2025	107500	17344361.75
10b5-1 Sales for ATTICUS ENTERPRISES LLC 1800 Avenue of the Stars, Suite 1400 Los Angeles CA 90067	Common	05/20/2025	150000	24955305.00
10b5-1 Sales for ATTICUS ENTERPRISES LLC 1800 Avenue of the Stars, Suite 1400 Los Angeles CA 90067	Common	05/19/2025	93184	15735646.62
10b5-1 Sales for ATTICUS ENTERPRISES LLC 1800 Avenue of the Stars, Suite 1400 Los Angeles CA 90067	Common	05/16/2025	182108	30970870.82

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares are being reported for sale in the ARES Form 144?

The notice reports a proposed sale of 56,204 common shares of Ares.

When were the shares being sold originally acquired?

The shares were acquired as founders shares on 05/02/2014 and payment was recorded the same date.

Who executed recent 10b5-1 sales disclosed in the filing?

The filing lists ATTICUS ENTERPRISES LLC as the seller for multiple 10b5-1 sales in May 2025.

How many Ares shares are outstanding according to the filing?

The filing states approximately 215,934,693 shares outstanding.

What were the gross proceeds from the May 2025 10b5-1 sales?

Reported gross proceeds include $30,970,870.82 (05/16), $15,735,646.62 (05/19), $24,955,305.00 (05/20), and $17,344,361.75 (05/21).